Freyer, Gilles <br/><br/>
Pharmacogenetic tailoring of irinotecan-based first-line chemotherapy in metastatic colorectal cancer: results of a pilot study.  [electronic resource] 

 -  Anticancer research  Jan 2011 
 - 359-66 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1791-7530 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Camptothecin--analogs & derivatives<br/>Colorectal Neoplasms--drug therapy<br/>DNA, Neoplasm--genetics<br/>Female<br/>Fluorouracil--therapeutic use<br/>Follow-Up Studies<br/>Genotype<br/>Glucuronosyltransferase--genetics<br/>Humans<br/>Leucovorin--therapeutic use<br/>Liver Neoplasms--drug therapy<br/>Lung Neoplasms--drug therapy<br/>Lymphatic Metastasis<br/>Male<br/>Middle Aged<br/>Mutation--genetics<br/>Neoplasm Staging<br/>Pharmacogenetics<br/>Pilot Projects<br/>Polymerase Chain Reaction<br/>Survival Rate<br/>Thymidylate Synthase--genetics<br/>Treatment Outcome<br/>Young Adult